The Small-Molecule Flunarizine in Spinal Muscular Atrophy Patient Fibroblasts Impacts on the Gemin Components of the SMN Complex and TDP43, an RNA-Binding Protein Relevant to Motor Neuron Diseases
The motor neurodegenerative disease spinal muscular atrophy (SMA) is caused by alterations of the survival motor neuron 1 (SMN1) gene involved in RNA metabolism. Although the disease mechanisms are not completely elucidated, SMN protein deficiency leads to abnormal small nuclear ribonucleoproteins (...
Main Authors: | Delphine Sapaly, Perrine Delers, Jennifer Coridon, Badih Salman, Franck Letourneur, Florent Dumont, Suzie Lefebvre |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmolb.2020.00055/full |
Similar Items
-
Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
by: Yuri Yépez, et al.
Published: (2020-06-01) -
The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
by: Niko Hensel, et al.
Published: (2020-02-01) -
Genetic pattern of SMN1, SMN2, and NAIP genes in prognosis of SMA patients
by: Heba Amin Hassan, et al.
Published: (2020-01-01) -
The Frequency of SMN1, SMN2 Copy Numbers in 246 Turkish Cases Analyzed with MLPA Method
by: Sinem Yalcintepe, et al.
Published: (2023-06-01) -
Evaluation of Mean Percentage of Full-Length SMN Transcripts as a Molecular Biomarker of Spinal Muscular Atrophy
by: Marianna Maretina, et al.
Published: (2022-10-01)